RevCore for In Stent Thrombosis

Inclusion criteria

• Age ≥ 18 years
• Patients with stent age > 6 weeks
• Location of thrombosed stents in proximal lower extremity deep vein segments including at least common femoral, external iliac, or common iliac vein
• RevCore Thrombectomy Catheter must enter vasculature
• Willing and able to provide informed consent

Exclusion criteria

• Exposed stents with broken struts, significantly deformed struts, struts protruding into the vessel
• Stents not wall apposed
• Stents compressed to <10mm
• Bilateral in-stent thrombosis
• Congenital anatomic anomalies of the iliac veins
• Allergy, hypersensitivity, or thrombocytopenia from heparin or iodinated contrast agents, except for mild to moderate contrast allergies for which pretreatment can be used
• Any contraindication to anticoagulants or antiplatelets that, in the opinion of the Investigator, cannot be medically managed throughout the study period
• Chronic non-ambulatory status
• Known hypercoagulable states (e.g. antiphospholipid syndrome) that, in the opinion of the Investigator, cannot be medically managed throughout the study period
• Inability to secure venous access
• Subject has any condition for which, in the opinion of the Investigator, participation would not be in the best interest of the subject
• Current participation in another investigational drug or device treatment study